Saudi Arabia Preclinical Cro Market Size & Outlook
Related Markets
Saudi Arabia preclinical cro market highlights
- The Saudi Arabia preclinical cro market generated a revenue of USD 12.3 million in 2025 and is expected to reach USD 21.6 million by 2033.
- The Saudi Arabia market is expected to grow at a CAGR of 7.4% from 2026 to 2033.
- In terms of segment, preclinical optimization, efficacy & pk/pd was the largest revenue generating development stage in 2025.
- Early CMC / Phase I–II Supply is the most lucrative development stage segment registering the fastest growth during the forecast period.
Preclinical cro market data book summary
| Market revenue in 2025 | USD 12.3 million |
| Market revenue in 2033 | USD 21.6 million |
| Growth rate | 7.4% (CAGR from 2026 to 2033) |
| Largest segment | Preclinical optimization, efficacy & pk/pd |
| Fastest growing segment | Early CMC / Phase I–II Supply |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Target Discovery, Preclinical Optimization, Efficacy & PK/PD, IND-Enabling Safety (GLP), Bioanalysis & Analytics, Early CMC / Phase I–II Supply |
| Key market players worldwide | Eurofins Scientific SE, Icon PLC, Wuxi AppTec Co Ltd, Medpace Holdings Inc, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc, Intertek Group PLC, Labcorp Holdings Inc, Crown Bioscience, SGA |
Other key industry trends
- In terms of revenue, Saudi Arabia accounted for 0.2% of the global preclinical cro market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Middle East & Africa, South Africa preclinical cro market is projected to lead the regional market in terms of revenue in 2033.
- Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 21.6 million by 2033.
Preclinical optimization, efficacy & pk/pd was the largest segment with a revenue share of 39.02% in 2025. Horizon Databook has segmented the Saudi Arabia preclinical cro market based on target discovery, preclinical optimization, efficacy & pk/pd, ind-enabling safety (glp), bioanalysis & analytics, early cmc / phase i–ii supply covering the revenue growth of each sub-segment from 2021 to 2033.
In 2023, Saudi Arabia held a share of 20.37% in the MEA market. Demand in the country can be attributed to the increasing demand for biosimilar & biological therapies, rising investments in R&D, and technological advancements, such as Artificial Intelligence (AI) & Big data.
The healthcare industry in Saudi Arabia is expected to gain substantial benefits from the integration of AI. The country is implementing significant AI-based measures to enhance its technological capabilities.
For instance, in May 2021, IQVIA, a leading health information technology, and clinical research company from the U.S., announced a cooperation with the Saudi Data and Artificial Intelligence Authority (SDAIA).
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Preclinical CRO Market Scope
Preclinical CRO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| SGA | View profile | 11-50 | Las Condes, Region Metropolitana, Chile, South America | https://sgasa.cl |
| Crown Bioscience | View profile | 251-500 | Santa Clara, California, United States, North America | http://www.crownbio.com |
| Intertek Group PLC | View profile | 44000 | 33 Cavendish Square, London, United Kingdom, W1G 0PS | https://www.intertek.com |
| Medpace Holdings Inc | View profile | 5800 | 5375 Medpace Way, Cincinnati, OH, United States, 45227 | https://www.medpace.com |
| Wuxi AppTec Co Ltd | View profile | 41116 | 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 | https://www.wuxiapptec.com |
| Icon PLC | View profile | 41150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | https://www.iconplc.com |
| Labcorp Holdings Inc | View profile | 67000 | 358 South Main Street, Burlington, NC, United States, 27215 | https://www.labcorp.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
| Eurofins Scientific SE | View profile | 61798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | https://www.eurofins.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
Saudi Arabia Development Stage - Preclinical Cro Market size, 2025 - 2033 (US$M)
Saudi Arabia Preclinical CRO Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
